Signaling through C5aR1 via the ligand C5a is known to contribute to neuroinflammation and pathology in neurogenerative diseases [68–71], and high concentrations of C5a can compromise the innate immune response [72–74]. Here, C5 is linked to glycogen storage disease VI.